Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
MS-patiënten hebben geen verhoogde kans op COVID-19
nov 2020 | Multipele Sclerose